Share on

Global Lung Cancer Surgery Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Procedure, Device & Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 1895
Pages: 180
Formats: report pdf report excel report power bi report ppt

Lung Cancer Surgery Market Size (2022 to 2027)

The global lung cancer surgery market size is estimated to value USD 42.13 billion by 2027 from USD 30.15 billion in 2022, growing at a CAGR of 6.92% during the forecast period.

Lung cancer sometimes referred to as lung carcinoma, is a malignant lung tumor marked by uncontrolled cell growth in lung tissues. People who use a lot of nicotine or who smoke are more likely to get lung cancer. Lung cancer risk rises with time and with the number of cigarettes smoked by an individual. Biopsy, which is performed under bronchoscopy or CT guidance, includes treatment of lung cancer. The surgical removal of cancerous tissue from the lungs is known as lung cancer surgery.  Small cell lung cancer and non-small cell lung cancer are the two most common forms of lung cancer. The type of surgery is determined by the tumor's location and size within the lung. The tumor is removed using a surgical technique or process. After surgery, some patients have discomfort and problems, although these are generally managed by medicine.


The global lung cancer surgery market is being driven by an increase in the prevalence of lung cancer and increasing levels of general public awareness about cancer treatment, and ongoing advancements in surgery equipment.

Increased risk factors among expanding tobacco smokers and a growing elderly population are boosting the industry's expansion. Furthermore, technical improvements in cancer therapy, a growing trend toward early cancer detection and treatment, and a positive reimbursement outlook contribute to the industry's growth. An increase in air pollution is the primary factor that drives the global lung cancer surgery market growth. Rising incidences of cancer incidences globally are another factor propelling the worldwide lung cancer surgery market demand. Increasing knowledge about cancer and the availability of treatments for cancer, along with the favorable reimbursement in the developed and developing countries, are accelerating the growth rate of this market.

Additionally, many other factors expected to fuel growth in the global lung cancer surgery market over the forecast period include the introduction of advanced healthcare infrastructure, an increase in smokers, and a reduction in the time required for lung cancer surgeries using new advanced technologies. Increased technological advancement and up gradation in lung cancer treatment and increased government funding for research and development of new drugs and treatment procedures are the major factors driving the lung cancer surgery market. With the growth of technological advancements in automation, robotic surgeries for surgical procedures are gaining popularity and acceptability among healthcare professionals. Robotic operations are minimally intrusive, which makes them more comfortable for patients. The existing markets like Brazil, India, and China, offer significant opportunities for the market players in the lung cancer surgery market.

Growing purchase power has enabled the patient population in existing countries to opt for technologically advanced material services and solutions. This attribute is regarded to drive the demand for advanced medical devices and the spread of surgery products.


The factors that hamper the market growth are lack of surgery knowledge, effective alternative treatments, and limited quality of being easy to obtain novel approaches, sudden and expected location, the large size of the tumor, pain after the surgery, and high cost. To overcome the challenges, few companies offer a growing portfolio of specially focused solutions designed to improve the health and quality of people’s lives around the world. This portfolio is known for new devices that simplify complex procedures.

Additionally, the global lung cancer surgery market is anticipated to be restrained by a shortage of competent experts for lung cancer treatment and a lack of adequate infrastructure in emerging nations throughout the forecast period. Furthermore, the high cost of lung cancer operations is one of the key factors expected to restrict the market expansion and pose additional challenges to the lung cancer surgery market.

Impact of COVID-19 on the global lung cancer surgery market:

COVID-19's fast spread, high death rates in populations, a lack of regular anti-tumor therapies, and widespread quarantine measures have all impacted cancer patients' psychological well-being, even leading to mental health issues. With nations affected by the pandemic, the number of cancer screening and diagnostic procedures dropped drastically. According to a preliminary analysis of the US market, the number of newly diagnosed metastatic non-small-cell lung cancer patients has decreased. Patients, particularly cancer patients with delayed admittance, require immediate psycho-oncological assistance. Cancer patients were more likely to link physical discomfort with COVID-19 and more hypersensitive to physiological changes, including coughing, dyspnea, tiredness, and other signs and symptoms. Due to frequent contact with the healthcare system, immunocompromised state from cancer or associated treatments, supportive medicines such as steroids, and most significantly, advanced age and illness, cancer patients are extremely prone to SARS-CoV-2 infections. By considering all these, the Lung Cancer Surgery Market has a negative impact due to this pandemic.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Analysed

By Procedure, Device & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Companies Analysed

Ethicon US LLC, Intuitive Surgical Inc., AngioDynamics Inc., Olympus Corporation, Accuray Inc., Ackermann Instrumente GmbH, Teleflex Inc., KARL STORZ GmbH, Scanlan International Inc., and Trokamed GmbH.


This research report on the global lung cancer surgery market has been segmented and sub-segmented based on procedure, device, and region.

Lung Cancer Surgery Market - By Procedure:

  • Thoracotomy
    • Lobectomy
    • Pneumonectomy
    • Sleeve Resection
    • Segmentectomy
  • Minimally Invasive

Based on the Procedure, the segmentectomy segment is predicted to account for a significant share in the global market during the forecast period. Non-small cell lung cancer can be treated with a segmentectomy, a frequent surgical procedure (NSCLC). If the patient already has a severely depleted lung reserve, it is usually preferred over lobectomy. Although lung segmentectomy has long been popular for excision of supporting lesions and non-malignant masses, it is most often indicated for lung cancer that is still in its early stages. This procedure gains popularity due to better results, less discomfort, and a faster recovery time than standard surgical techniques. In addition, the segmentectomy treatment has a high success rate for eliminating localized tumors and cancers, with greater survival rates and the ability to retain organ functioning to some extent, and these benefits are expected to drive the market expansion.

The minimally invasive surgeries segment is anticipated to grow at an aggressive rate during the forecast period. The increased use of minimally invasive methods, technical developments, reimbursement regulations, and the expanding trend of robotic operations are all factors driving this market segment's rise in the future.

Lung Cancer Surgery Market - By Device:

  • Surgical
    • Clamps
    • Forceps
    • Retractors
    • Staplers
    • Cutters
    • Scissors
    • Elevators
    • RIB Sheers
    • Trocars
  • Monitoring
    • Cameras
    • Video Support
  • Visualizing Systems
    • Endoscopic Trocars with optical views
    • Endo surgical Equipment

Based on Device, the surgical segment held the largest share of the market in 2020. The market is being driven by rising lung cancer prevalence and incidence, increased government support and financing, and increased use of surgical techniques for lung cancer therapy.

Lung Cancer Surgery Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North America dominates the global lung cancer surgery market from 2021 to 2026. An increase in population’s age day-wise, the rising occurrence rate of lung cancer, and reimbursement available for lung cancer surgery are the factors that drive the market in the North American region. In addition, the advanced healthcare infrastructure that supports technologically advanced surgeries like robotic surgery is likely to bolster the demand of the market. Because of the availability of suitable healthcare infrastructure and the rising prevalence of lung cancer, North America accounted for the largest revenue share in the worldwide lung cancer surgery market. Furthermore, technological advancements in surgical methods are projected to drive the growth of the worldwide lung cancer surgery market. Lung cancer has been diagnosed in the majority of patients in the previous five years. Non-small cell lung cancer is cured in tens of thousands of patients in the United States each year. Lung cancer is a disease that primarily affects the elderly. This reflects the high prevalence of lung cancer in this nation, which has resulted in the market's expansion due to the strong demand for cancer treatment.

Asia ranks as the fastest-growing segment due to the growing population, high commonness of cancer, and rising knowledge campaigns. These countries are anticipated to witness high growth due to the less strict regulation policies and low competition. As a result, Asia-Pacific is expected to produce more. The expensive nature of robotic surgeries can be a problem in existing Asia Pacific regions such as India and China. Due to quickly growing healthcare infrastructure, rising patient awareness, and acceptance of technologically developed robotic operations in Japan and emerging economies such as India and China, Asia Pacific is projected to be the most lucrative market.


Some of the notable companies leading the global lung cancer surgery market profiled in this report are Ethicon US LLC, Intuitive Surgical Inc., Olympus Corporation, Accuray Inc., AngioDynamics Inc., Teleflex Inc., KARL STORZ GmbH, Ackermann Instrumente GmbH, Scanlan International Inc. and Trokamed GmbH.


  • On August 15, 2018, the acquirer of Biosentry was used to prevent pneumothorax during the CT- guided lung biopsies using a hydrogel plug, which prevents air leakage in the procedure. This acquisition was done by AngioDynamic’s through BioSentry sealant and received both FDA and CE mark approval.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample